Celyad focuses on translating promising research into transformative treatments aimed at reversing the outcome of severe diseases. Celyad identifies and further advances therapeutic solutions that have the potential to change the lives of thousands of patients worldwide.
Our scientific approach is inspired by natural mechanisms that are used by the body to fight disease. We put all our efforts into developing and delivering best-in-class therapies that will re-engage these natural mechanisms in patients. We know that every second counts for patients, this is what drives us in our work every day.

Type
Public
HQ
Mont Saint Guibert, BE
Founded
2007
Size (employees)
82 (est)
Website
celyad.com
Celyad was founded in 2007 and is headquartered in Mont-Saint-Guibert, BE

Celyad Office Locations

Celyad has offices in Mont-Saint-Guibert and Boston
Mont Saint Guibert, BE (HQ)
2 Rue Edouard Belin
Boston, US
2 Seaport Ln

Celyad Data and Metrics

Celyad Financial Metrics

EUR

Market capitalization (22-Mar-2017)

190.4 b

Closing share price (22-Mar-2017)

20.2
Celyad's current market capitalization is €190.4 b.

Celyad Market Value History

Celyad Online and Social Media Presence

Celyad Company Life and Culture

You may also be interested in